Cordlife Group (SGX:P8A) has received full test results for over 200 donated cord blood samples stored in five cryogenic tanks previously flagged for potential temperature excursions, according to a Wednesday filing on the Singapore Exchange.
The stem cell banking firm is conducting a technical analysis of the findings with professional advisers and specialists.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.